Financial institutions in the region are feeling the heat from increasingly aggressive regulatory actions following landmark AML cases involving Hong Kong and Chinese banks
How industry barrier changes in the previous and new versions of the Foreign Investment Catalogue--and the introduction of the Negative List system--impact market access compliance
Businesses await clarity on scope and procedure following a set of a draft rules that mandate security assessments for exporting personal and important data in critical fields
The CSRC's crackdown on securities fraud has sparked a series of disputes between listed companies and their shareholders, paving the way for rights defense lawyers and steering key judicial practices
The redesigned 2017 Negative List applicable to China's 11 free trade zones signifies another big step forward for the nation's foreign investment regime
The CAC's regulations governing reviews of network products and services focus on security and controllability, but companies await clarity on the scope of “critical information infrastructure”
The updated regulations for establishing regional headquarters in Shanghai offer multinational companies greater clarity on eligibility, approval processes and specific advantages
China launches a “Two-Invoice System” to simplify the drug distribution chain and reduce prices and corruption in the healthcare sector. The new policy may bring substantial compliance and business model challenges for pharmaceutical companies
